Table 3:
Compound | Half-life (HLM) (hr) | % left after 1 hr. (HLM) | Half-life (MLM) (hr) | % left after 1 hr. (MLM) |
---|---|---|---|---|
8ap | 3.6 ± 0.6 | 86.10 ± 0.71 | 3.2 ± 0.1 | 80.35 ± 0.10 |
8bb,p | 8.7 ± 0.6 | 91.69 ± 0.09 | 10.5 ± 0.9 | 92.80 ± 0.07 |
8cb,p | 11.1 ± 3.6 | 92.00 ± 0.21 | 14.3 ± 2.8 | 93.17 ± 0.11 |
8db,p | 13.0 ± 3.0 | 91.51 ± 0.13 | 14.1 ± 3.2 | 93.08 ± 0.14 |
8eb,m | 7.7 ± 1.1 | 89.50 ± 0.14 | 9.9 ± 1.9 | 90.50 ± 0.15 |
8fb,o | 9.9 ± 1.5 | 90.50 ± 0.14 | 13.9 ± 4.2 | 92.00 ± 0.18 |
8gb,m | 3.9 ± 0.3 | 81.28 ± 0.15 | 14.5 ± 4.2 | 91.56 ± 0.23 |
8hb,o | 3.5 ± 0.2 | 79.92 ± 0.14 | 10.9 ± 1.5 | 93.04 ± 0.09 |
13ab,e | 13.2 ± 2.2 | 92.85 ± 0.10 | 2.3 ± 0.1 | 74.77 ± 0.09 |
13bb,e | 9.9 ± 1.1 | 92.58 ± 0.09 | 10.7 ± 1.2 | 92.39 ± 0.09 |
13cb,e | 12.5 ± 3.1 | 92.30 ± 0.10 | 9.2 ± 0.9 | 91.38 ± 0.09 |
13db,e | 9.8 ± 2.8 | 90.00 ± 0.32 | 14.5 ± 4.8 | 92.50 ± 0.23 |
13ib,f | 10.6 ± 2.7 | 91.00 ± 0.20 | 12.0 ± 4.0 | 93.00 ± 0.30 |
8im | 3.4 ± 0.2 | 81.44 ± 0.16 | 1.5 ± 0.1 | 59.83 ± 0.17 |
8jc,m | 10.8 ± 1.0 | 93.00 ± 0.09 | 2.8 ± 0.1 | 76.59 ± 0.08 |
8kc,p | 2.3 ± 0.1 | 72.50 ± 0.11 | 1.9 ± 0.1 | 69.20 ± 0.11 |
8lc,p | 10.7 ± 1.5 | 92.20 ± 0.15 | 4.4 ± 0.3 | 85.54 ± 0.05 |
8mc,o | 16.5 ± 1.8 | 94.80 ± 0.07 | 16.6 ± 2.0 | 94.91 ± 0.07 |
13ec,e | 8.5 ± 0.5 | 91.60 ± 0.10 | 4.4 ± 0.2 | 85.62 ± 0.08 |
13fc,e | 12.1 ± 1.9 | 93.00 ± 0.12 | 4.2 ± 0.2 | 85.11 ± 0.07 |
8np | 1.7 ± 0.1 | 66.86 ± 0.13 | 1.9 ± 0.1 | 68.96 ± 0.12 |
8od,p | 3.4 ± 0.1 | 81.50 ± 0.11 | 2.3 ± 0.1 | 73.85 ± 0.11 |
8pd,m | 1.8 ± 0.1 | 63.50 ± 0.32 | 3.6 ± 0.3 | 79.50 ± 0.20 |
8qd,o | 14.2 ± 3.0 | 92.85 ± 0.11 | 1.5 ± 0.3 | 61.31 ± 0.15 |
13gd,e | 12.1 ± 1.4 | 93.40 ± 0.11 | 11.4 ± 1.4 | 93.13 ± 0.09 |
13hd,e | 38.6 ± 7.7 | 97.80 ± 0.06 | 70.8 ± 25.8 | 98.39 ± 0.04 |
Compounds were incubated with HLM or MLM for 60 minutes and quantified by LC-MS/MS.
8a related analogs in red.
8i related analogs in blue.
8n related analogs in green.
D-ring N-hetero analogs.
A-ring N-hetero analogs.
D-ring “ortho”.
D-ring “meta”.
D-ring “para”.